Nicotinamide phosphoribosiltransftrase is a proinflammatori molecule characterizing severiti of rheumatoid arthritis
Abstract
Nicotinamide phosphoribosyltransferase (NAMPT) stimulates synthesis of matrix metalloproteinases and chemokines, which support synovial inflammation caused by leukocyte infiltration. A positive correlation between NAMPT and C-reactive protein confirms the role of NAMPT as an inflammatory mediator. Increased concentrations of NAMPT are considered stimulators of systemic inflammation.
The aim of this study was to evaluate serum concentrations of NAMPT in patients with rheumatoid arthritis.
Methods. Serum concentration of NAMPT was determined by indirect enzyme-linked immunosorbent assay with commercial kits (RaiBiotech, cat.# EIA-VIS-1) according to the manufacturer’s instructions.
Results. Elevated serum NAMPT was detected in 84.29% of patients. Rheumatoid arthritis patients with higher NAMPT concentrations significantly more likely had a higher activity score DAS28 (disease activity degree II), a high level of antibodies to citrullinated peptide vimentin, higher levels of C-reactive protein, and higher red blood cell sedimentation rate.
Conclusion. NAMPT can be regarded as an important component of the pathogenesis of rheumatoid arthritis and a candidate target molecule for therapy.